These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7903830)

  • 41. Benefit of primary prophylaxis before 18 months of age in reducing the incidence of Pneumocystis carinii pneumonia and early death in a cohort of 112 human immunodeficiency virus-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group.
    Thea DM; Lambert G; Weedon J; Matheson PB; Abrams EJ; Bamji M; Straus WL; Thomas PA; Krasinski K; Heagarty M
    Pediatrics; 1996 Jan; 97(1):59-64. PubMed ID: 8545225
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Defining the population of human immunodeficiency virus-infected children at risk for Mycobacterium avium-intracellulare infection.
    Lewis LL; Butler KM; Husson RN; Mueller BU; Fowler CL; Steinberg SM; Pizzo PA
    J Pediatr; 1992 Nov; 121(5 Pt 1):677-83. PubMed ID: 1432413
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
    Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
    Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytomegalovirus seropositivity and human immunodeficiency virus type 1 RNA levels in individuals with hemophilia.
    Sabin CA; Devereux HL; Clewley G; Emery VC; Phillips AN; Loveday C; Lee CA; Griffiths PD
    J Infect Dis; 2000 May; 181(5):1800-3. PubMed ID: 10823788
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells.
    French M; Keane N; McKinnon E; Phung S; Price P
    HIV Med; 2007 Apr; 8(3):148-55. PubMed ID: 17461858
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy.
    Kirk O; Reiss P; Uberti-Foppa C; Bickel M; Gerstoft J; Pradier C; Wit FW; Ledergerber B; Lundgren JD; Furrer H;
    Ann Intern Med; 2002 Aug; 137(4):239-50. PubMed ID: 12186514
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain?
    Medrano FJ; Hernández-Quero J; Jiménez E; Pineda JA; Rivero A; Sánchez-Quijano A; Velez ID; Viciana P; Castillo R; Reyes MJ
    AIDS; 1992 Dec; 6(12):1499-503. PubMed ID: 1362880
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of routine use of therapy in slowing the clinical course of human immunodeficiency virus (HIV) infection in a population-based cohort.
    Longini IM; Clark WS; Karon JM
    Am J Epidemiol; 1993 Jun; 137(11):1229-40. PubMed ID: 8100682
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Study of prevalence, severity, and etiological factors associated with acute pancreatitis in patients infected with human immunodeficiency virus.
    Dutta SK; Ting CD; Lai LL
    Am J Gastroenterol; 1997 Nov; 92(11):2044-8. PubMed ID: 9362189
    [TBL] [Abstract][Full Text] [Related]  

  • 50. AIDS and thrombosis: retrospective study of 131 HIV-infected patients.
    Saif MW; Bona R; Greenberg B
    AIDS Patient Care STDS; 2001 Jun; 15(6):311-20. PubMed ID: 11445013
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of opportunistic disease on survival in patients with HIV infection.
    Chaisson RE; Gallant JE; Keruly JC; Moore RD
    AIDS; 1998 Jan; 12(1):29-33. PubMed ID: 9456252
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team.
    Hughes MD; Johnson VA; Hirsch MS; Bremer JW; Elbeik T; Erice A; Kuritzkes DR; Scott WA; Spector SA; Basgoz N; Fischl MA; D'Aquila RT
    Ann Intern Med; 1997 Jun; 126(12):929-38. PubMed ID: 9182469
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mycobacterium xenopi infection in patients with human immunodeficiency virus infection.
    el-Helou P; Rachlis A; Fong I; Walmsley S; Phillips A; Salit I; Simor AE
    Clin Infect Dis; 1997 Aug; 25(2):206-10. PubMed ID: 9332511
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985-1991.
    Muñoz A; Schrager LK; Bacellar H; Speizer I; Vermund SH; Detels R; Saah AJ; Kingsley LA; Seminara D; Phair JP
    Am J Epidemiol; 1993 Feb; 137(4):423-38. PubMed ID: 8096356
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection. An investigation of cases in the United States. The Centers for Disease Control Idiopathic CD4+ T-lymphocytopenia Task Force.
    Smith DK; Neal JJ; Holmberg SD
    N Engl J Med; 1993 Feb; 328(6):373-9. PubMed ID: 8093633
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predictors of Pneumocystis carinii pneumonia in HIV-infected persons. Pulmonary Complications of HIV Infection Study Group.
    Stansell JD; Osmond DH; Charlebois E; LaVange L; Wallace JM; Alexander BV; Glassroth J; Kvale PA; Rosen MJ; Reichman LB; Turner JR; Hopewell PC
    Am J Respir Crit Care Med; 1997 Jan; 155(1):60-6. PubMed ID: 9001290
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Change in T-lymphocyte count after initiation of highly active antiretroviral therapy in HIV-infected patients with history of Mycobacterium avium complex infection.
    Lazaro E; Coureau G; Guedj J; Blanco P; Pellegrin I; Commenges D; Dabis F; Moreau JF; Pellegrin JL; Thiébaut R;
    Antivir Ther; 2006; 11(3):343-50. PubMed ID: 16759051
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A pilot study of sequential therapy with zidovudine plus acyclovir, dideoxyinosine, and dideoxycytidine in patients with severe human immunodeficiency virus infection.
    Nguyen BY; Shay LE; Wyvill KM; Pluda JM; Brawley O; Cohen RB; Whitcup SM; Venzon DJ; Broder S; Yarchoan R
    J Infect Dis; 1993 Oct; 168(4):810-7. PubMed ID: 8397267
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Asymptomatic CMV Replication During Early Human Immunodeficiency Virus (HIV) Infection Is Associated With Lower CD4/CD8 Ratio During HIV Treatment.
    Smith DM; Nakazawa M; Freeman ML; Anderson CM; Oliveira MF; Little SJ; Gianella S
    Clin Infect Dis; 2016 Dec; 63(11):1517-1524. PubMed ID: 27601222
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons.
    Crowe SM; Carlin JB; Stewart KI; Lucas CR; Hoy JF
    J Acquir Immune Defic Syndr (1988); 1991; 4(8):770-6. PubMed ID: 1677419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.